Skip to main content Skip to main navigation menu Skip to site footer

The efficacy of magnesium sulfate administration in diffuse axonal injury cases

  • Yoki Oktadi Putra ,
  • Syaiful Saanin ,
  • Hesty Lidya Ningsih ,


Introduction: Diffuse axonal injury is a type of severe head injury. In overall head injury cases, it is estimated that 60% of severe head injuries and 40% of head injury cases were associated with diffuse axonal injury. Diffuse axonal injury is found in secondary brain injury with the occurrence of an ischemic brain. Magnesium sulfate plays a role as a deciphering agent in severe head injury and ischemic brains. This study was conducted to investigate the efficacy of magnesium sulfate administration in patients with diffuse axonal injury.

Methods: This research was conducted using a quasi-experimental design for three months, from October to December 2019, involving patients with severe head injury admitted to the emergency room of Dr. M. Djamil General Hospital, Padang.

Results: The results showed that magnesium sulfate administration was more effective than conventional therapy in improving the level of consciousness of patients with severe head injuries, but there was no significant difference between the two groups (p > 0.05). The number of patients was equally analyzed between the two study groups using independent t-test analysis on SPSS.

Conclusion: Magnesium sulfate administration was more effective than conventional therapy, but the difference was not statistically significant. Age and onset must be considered by researchers to assess the performance of magnesium sulfate therapy in diffuse axonal injury patients.

 Keywords: diffuse axonal injury, magnesium sulfate, severe head injury


  1. Zhao L, Wang W, Zhong J, Li Y, Cheng Y, Su Z, Zheng W, Guan XD. The effects of magnesium sulfate therapy after severe diffuse axonal injury. Ther Clin Risk Manag. 2016; 12: 1481–1486. DOI: 10.2147/TCRM.S109482.
  2. Davies, DJ. Supplementary Magnesium in Traumatic Brain Injury: where do we go from here?â€. J R Army Med Corps. 2018; 164(6): 397-398. DOI: 10.1136/jramc-2018-000985.
  3. Smith DH, Meaney DF, Shull WH. Diffuse Axonal Injury in Head Trauma. J Head Trauma Rehabil. 2003; 18(4): 307–16. DOI: 10.1097/00001199-200307000-00003.
  4. Dhandapani SS, Gupta A, Vivekanandhan S, Sharma BS, Mahapatra AK. A randomized controlled trial of magnesium sulfate in severe closed traumatic brain injury. IJNT. 2008; 5(1): 27-33. DOI: 10.1016/s0973-0508(08)80025-1.
  5. Vink R, Cook NL, Van den Heuvel C. Magnesium in acute and chronic brain injury; an update. Magnesium Research. 2009; 22(3): 158S-62S. DOI: 10.1684/mrh.2009.0175.
  6. Smith DH, Hicks R, Povlishock JT. Therapy development for diffuse axonal injury. J Neurotrauma. 2013; 30(5): 307 – 23. DOI: 10.1089/neu.2012.2825.
  7. Takaoka M, Tabuse H, Kamura E, Nakajima S, Tsuzuki T, Nakamura K, Okada A, Sugimoto H. Diffuse Axonal Injury. In: Magnetic Resonance of Myelination and Myelin Disorders. Berlin: Springer; 2005. p. 823-831.
  8. Li W, Bai YA, Li YJ, Liu KG, Wang MD, Xu GZ, Shang HL, Li YF. Magnesium Sulfate for Acute Traumatic Brain Injury. J Craniofac Surg. 2015; 26(2): 393-8. DOI: 10.1097/SCS.0000000000001339.
  9. Sen AP, Gulati A. Use of Magnesium in Traumatic Brain Injury. Neurotherapeutics. 2010; 7(1): 91-9. DOI: 10.1016/j.nurt.2009.10.014.
  10. IOM (Institute of Medicine). Erdman J, Oria M, Pillsbury L. Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Health Outcomes in Military Personnel. Washington, DC: The National Academies Press; 2011.
  11. Heath DL, Vink R. Neuroprotective Effects of MgSO4 and MgCl2 in Closed Head Injury: A Comparative Phosphorus NMR Study. J Neurotrauma. 1998; 15(3): 183-9. DOI: 10.1089/neu.1998.15.183.
  12. Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucas T, Newell DW, Mansfield PN, Machamer JE, Barber J. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomized controlled trial. Lancet Neurology. 2007; 6(1): 29â€38. DOI: 10.1016/S1474-4422(06)70630-5.
  13. Jain KK. Neuroprotection in Traumatic Brain Injury. In: The Handbook of Neuroprotection. New York: Humana; 2019. p. 281-336.
  14. Esen F, Erdem T, Aktan D, Kalayci R, Cakar N, Kaya M, Telci L. Effects of Magnesium Administration on Brain Edema and Blood-Brain Barrier Breakdown After Experimental Traumatic Brain Injury in Rats. J Neurosurg Anesthesiol. 2003; 15(2): 119-25. DOI: 10.1097/00008506-200304000-00009.
  15. Inglese M, Makani S, Johnson G, Cohen BA, Silver JA, Gonen O, Grossman RI. Diffuse axonal injury in mild traumatic brain injury: a diffusion tensor imaging study. J Neurosurg. 2005;103(2): 298-303. DOI: 10.3171/jns.2005.103.2.0298.
  16. Humble SS, Wilson LD, Wang L, Long DA, Smith MA, Siktberg JC, Mirhoseini MF, Bhatia A, Pruthi S, Day MA, Muehlschlegel S. Prognosis of diffuse axonal injury with traumatic brain injury. J Trauma Acute Care Surg. 2018; 85(1): 155-159. DOI: 10.1097/TA.0000000000001852.
  17. Mittal P. Diffuse axonal injury: pathological and clinical aspects. Forensic Res Criminol Int J. 2015; 1(4): 157-160. DOI: 10.15406/frcij.2015.01.00026.
  18. Adams JH, Doyle D, Ford I, Gennarelli TA, Graham DI, Mclellan DR. Diffuse axonal injury in head injury: Definition, diagnosis, and grading. Histopathology. 1989;15: 49-59. DOI: 10.1111/j.1365-2559.1989.tb03040.x.
  19. Hammoud DA, Wasserman BA. Diffuse axonal injuries: pathophysiology and imaging. Neuroimaging Clin N Am. 2002; 12(2): 205-16. DOI: 10.1016/s1052-5149(02)00011-4.

How to Cite

Putra, Y. O., Saanin, S., & Ningsih, H. L. (2020). The efficacy of magnesium sulfate administration in diffuse axonal injury cases. Indonesian Journal of Neurosurgery, 3(1).




Search Panel

Yoki Oktadi Putra
Google Scholar
IJN Journal

Syaiful Saanin
Google Scholar
IJN Journal

Hesty Lidya Ningsih
Google Scholar
IJN Journal